Khiron Life Sciences Corp - Ordinary Shares

Khiron Life Sciences Corp - Ordinary Shares

Khiron Life Sciences Corp is a Canada based company involved in cultivating, producing, and distributing THC (tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. Some of the potential uses for medicinal cannabis are disease treatment, pain relief, and disease prevention, including: treatment of epilepsy; slow cell damage in diabetes glaucoma, lower intraocular pressure; treatment of Tourette syndrome among others.
Medical Resources
1d 5d 1m 6m 1y Max
1d 5d 1m 6m 1y Max

Khiron Life Sciences Corp - Ordinary Shares News

25 Jun

Khiron President Chris Naprawa to Participate in Grit Capital Virtual Investor Conference

TORONTO , June 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, announces today...

19 Jun

Khiron Completes Acquisition of NettaGrowth International Advancing Multi-Country Operator Strategy

TORONTO , June 19, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, announces that...

17 Jun

Khiron Life Sciences Corp. Joins the Stock Day Podcast to Discuss Expansion in Latin America

PHOENIX, AZ / ACCESSWIRE / June 17, 2019 / The Stock Day Podcast welcomed Khiron Life Sciences Corp. (KHRNF) ("the Company"), a vertically integrated cannabis leader with core operations in Latin America....

14 Jun

Khiron Announces Changes to Leadership Team with Appointment of Wendy Kaufman as CFO

TORONTO, June 14, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, today announced...

07 Jun

Khiron Receives Regulatory Approval for Uruguay Acquisition

TORONTO , June 7, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a medical cannabis company with core operations in Latin America reports that...

03 Jun

/R E P E A T -- Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Ext

TORONTO, June 2, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin...

02 Jun

Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year

TORONTO , June 2, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America...

31 May

Khiron Life Sciences Reports First Quarter Fiscal 2019 Financial Results

Khiron Life Sciences Reports First Quarter Fiscal 2019 Financial Results

30 May

Khiron Life Sciences to Webcast Live on June 4th at VirtualInvestorConferences.com

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com TORONTO , May 30, 2019 /PRNewswire/...

29 May

Khiron Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF

TORONTO , May 29, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America is pleased to announce today its...

Load more

Participation in events

$ 0.71
-2.22%
Open:
0.70
High:
0.73
Low:
0.69
Share volume:
185.587 K
Total value:
261.737 K
Market cap:
160.979 M
Symbol:
KHRNF